RedDrop Dx

medical devices

About

RedDrop Dx is a U.S.-based medical device company founded in 2019 by CEO Kris Buchanan. The company focuses on improving blood collection technology with innovative, pain-free solutions that enhance the blood draw process for both patients and healthcare providers. Their main product, RedDrop One, is a prescription-use device designed for whole blood and plasma collection. It allows for the collection of large blood volumes with significantly reduced discomfort compared to traditional methods. The device is suitable for various environments, including home health, point-of-care, and clinical trials. RedDrop One received FDA 510(k) clearance in March 2024, demonstrating its safety and effectiveness through clinical trials with a 97% success rate for self-collection. RedDrop Dx targets customers in the healthcare and life sciences sectors, particularly those involved in decentralized clinical trials and home health testing. Their technology addresses challenges in blood collection, improving access to reliable diagnostic testing while enhancing patient comfort.

Technologies

NSOne Gmail Google Apps Mobile Friendly Shopify Squarespace ECommerce Typekit Android Node.js Remote AI IoT

Keywords

biotechnology diagnostics medical manufacturing medical device healthcare medical equipment manufacturing medical device innovation fda cleared pain-free blood sampling blood testing solutions patient experience patented device blood sample collection device medical equipment and supplies manufacturing decentralized trials remote patient monitoring healthcare technology high success blood draw blood sampling blood draw technology services blood sample collection health tech blood collection innovation medical device industry healthcare solutions clinical trials blood sampling device blood collection for remote diagnostics decentralized clinical trials

Location

Fort Collins, Colorado, United States, 80525

Related Companies

Companies in the same industry